AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

By:
On:
URL has been copied successfully!

The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.

Share this story:
Share by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here